Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma(MM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01782963
What this trial is testing

Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Massachusetts General Hospital 50
Post-approval studies (Phase 4)Study completedNCT00352703
What this trial is testing

PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation

Who this might be right for
Non-Hodgkin's LymphomaMultiple Myeloma
Swedish Orphan Biovitrum 145
Not applicableEnded earlyNCT04770402
What this trial is testing

Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Wake Forest University Health Sciences 12
Testing effectiveness (Phase 2)Ended earlyNCT00648739
What this trial is testing

Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaMultiple Myeloma
Alexion Pharmaceuticals, Inc. 26
Early research (Phase 1)Study completedNCT00710528
What this trial is testing

Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Lymphoma, Non-Hodgkin (NHL)Acute Myeloid Leukemia (AML)+1 more
Gilead Sciences 192
Testing effectiveness (Phase 2)Ended earlyNCT01695330
What this trial is testing

Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens

Who this might be right for
Multiple Myeloma
Oncotherapeutics 5
Not applicableUnknownNCT02572596
What this trial is testing

Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients

Who this might be right for
Multiple Myeloma
Wang Guorong 200
Testing effectiveness (Phase 2)UnknownNCT05749133
What this trial is testing

Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
XuYan 18
Testing effectiveness (Phase 2)Study completedNCT02206503
What this trial is testing

Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 13
Testing effectiveness (Phase 2)Study completedNCT00777998
What this trial is testing

Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 221
Testing effectiveness (Phase 2)Looking for participantsNCT05405387
What this trial is testing

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
University of Utah 120
Large-scale testing (Phase 3)Active Not RecruitingNCT05827016
What this trial is testing

Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 1,230
Testing effectiveness (Phase 2)Study completedNCT01660633
What this trial is testing

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

Who this might be right for
Multiple Myeloma
Acrotech Biopharma Inc. 61
Early research (Phase 1)Active Not RecruitingNCT06325748
What this trial is testing

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

Who this might be right for
AML/MDSCD33 Expressing Hematological MalignanciesFLT3 Expressing Hematological Malignancies
Senti Biosciences 21
Early research (Phase 1)Study completedNCT03269136
What this trial is testing

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 101
Testing effectiveness (Phase 2)Study completedNCT00054158
What this trial is testing

Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute 24
Large-scale testing (Phase 3)Looking for participantsNCT05645107
What this trial is testing

Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Who this might be right for
HypogammaglobulinemiaBacterial InfectionsB-cell Chronic Lymphocytic Leukemia+2 more
Grifols Therapeutics LLC 386
Early research (Phase 1)Ended earlyNCT02579824
What this trial is testing

Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT03242460
What this trial is testing

The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM)

Who this might be right for
Relapsed and/or refractorY Multiple Myeloma
Kosin University Gospel Hospital 55
Not applicableStudy completedNCT01454297
What this trial is testing

Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

Who this might be right for
Multiple Myeloma
Multiple Myeloma Research Foundation 1,154
Next Page